Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers December 2012

Launches - A recapitulation of maiden launches in the last 30 days


Launches 275 hedge fund launches, 211 liquidations in Q3-12

New hedge fund launches and liquidations maintained the pace of recent quarters in 3Q12 despite the overhang of macroeconomic risks, political uncertainties and anticipated regulatory changes, according to data released by Hedge Fund Research (HFR), a provider of indexation, research and analysis for the global hedge fund industry.

Hedge fund launches totalled 275 in 3Q12, an increase from 245 in the prior quarter, bringing total launches in the trailing 12 months to 1,094 funds, slightly below the 2011 launch total of 1,113 fund openings.

Hedge fund liquidations increased to 211 in 3Q12, an uptick from the 192 liquidations in 2Q12, bringing total liquidations to 825 in the trailing 12 months, slightly ahead of the 2011 total of 775 fund closings.

Concurrent with total hedge fund industry assets reaching a record level of $2.2 trillion, the total number of singlemanager hedge funds also reached a record level of 7,867 funds in 3Q12. However, in contrast to this trend, and indicative of an increased propensity for investors to invest directly into hedge funds, the total number of Funds of Hedge Funds (FOF) in existence declined to fewer than 1,900, a level not seen since 1Q05.

Launches in both Macro and Relative Value Arbitrage (RV) strategies exceeded launches in Equity Hedge for the first time in 3Q12, with over 100 new Macro funds and over 70 new RV funds launching in 3Q12, compared to 60 launches in Equity Hedge.

We recently heard of this ex-hedge funder striking out on his own:

1.   ......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t